TOP TIERMARKET NEWSWIRE
News & sentiment

ARS PHARMACEUTICALS (SPRY) — News & AI sentiment

ARS PHARMACEUTICALS (SPRY) news roundup. 6 stories aggregated over the last 30 days. Average 30-day sentiment is 38/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
0
30d stories
6
avg sentiment 38/100
Insider net (90d)
$0
0 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

SPRY news in the last 24 hours, 7 days, 30 days and 90 days

How much SPRY coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowSPRY storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days0—no coverage
Last 30 days638/100SPRY headlines →
Last 90 days9543.1/100SPRY headlines →

Latest stories on SPRY

Oct 5
Oct 4
Oct 1
Sep 29
Sep 28
Sep 28
Sep 28
Sep 28
Sep 26
Sep 25
Sep 25
Sep 25
Sep 24
Sep 24
Sep 23
Sep 23
Sep 23
Sep 23
Sep 22
Sep 22
Sep 22
Sep 22
Sep 21
Sep 21
Sep 18
Open SPRY in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →